Mat Nor et al. [43] showed in a retinal light damage model of dry AMD as well as in a hyperglycaemic rat DR model that oral tonabersat treatment reduced the number of Iba-1+ cells and GFAP expression within retinal Müller cells. The gene discussed is AIF1; the disease is dry age related macular degeneration.